Everolimus for postmenopausal women with advanced breast cancer: Updated results of the BOLERO-2 phase III trial.
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Francis P. Arena, Shinzaburo Noguchi, Kathleen I. Pritchard, Howard A. Burris, Hope S. Rugo, Michael Gnant, Gabriel N. Hortobagyi, Luciano Latini, Denise Aysel Yardley, Bohuslav Melichar, Katarina Petrakova, Wael Harb, Wentao Feng, Ayelet Cahana, Tanya Taran, Mario Campone, José Baselga, Tarek Sahmoud, David Edward Lebwohl, Martine J. Piccart-Gebhart
Institutions: The University of Osaka, Sunnybrook Health Science Centre, University of Toronto, Odette Cancer Centre, Sarah Cannon, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Medical University of Vienna, The University of Texas MD Anderson Cancer Center, Ospedale di Macerata, Palacký University Olomouc, Masaryk Memorial Cancer Institute, Horizon Oncology Center, Novartis (United States), Institut de Cancérologie de l'Ouest, Massachusetts General Hospital, Institut Jules Bordet
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4240429779